You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CXCR4 (chemokine receptor)

Showing 1 - 25 of 7,530
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thymoma Trial in Beijing (68Ga-Pentixafor)

Recruiting
  • Thymoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Oct 11, 2023

Aldosterone-Producing Adenoma Trial in Chengdu ([18F]AlF-NOTA-pentixather PET/CT)

Recruiting
  • Aldosterone-Producing Adenoma
  • [18F]AlF-NOTA-pentixather PET/CT
  • Chengdu, Sichuan, China
    Sichuan Academy of Medical Sciences.Sichuan Provincial People's
Apr 3, 2023

Lymphoma, Multiple Myeloma, Leukemia Trial in Fuzhou (68Ga-Pentixafor)

Recruiting
  • Lymphoma
  • +2 more
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Apr 6, 2021

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • New York, New York
  • +1 more
Nov 7, 2022

Multiple Myeloma, Lymphoma Trial in Beijing (68Ga-Pentixafor)

Unknown status
  • Multiple Myeloma
  • Lymphoma
  • Beijing, China
    Department of Nuclear Medicine, Peking Union Medical College Hop
Dec 26, 2019

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Multiple Myeloma Trial in Beijing (68Ga-Pentixather, 68Ga-Pentixafor)

Recruiting
  • Multiple Myeloma
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 3, 2022

CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)

Not yet recruiting
  • CXCR4
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Feb 15, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

Idiopathic CD4-Positive, T-Lymphocytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting
  • Idiopathic CD4-Positive
  • T-Lymphocytopenia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 21, 2023

Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients

Active, not recruiting
  • Multiple Myeloma
  • Torino, Italy
    A.O.U. Città della Salute e della Scienza di Torino
Aug 17, 2021

Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,

Recruiting
  • Mycosis Fungoides
  • +2 more
  • Extracorporeal Photopheresis
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital
Jun 15, 2022

Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

Active, not recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Extracorporeal Photopheresis
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Advanced Solid Tumor, Breast Cancer, Non Small Cell Lung Cancer Trial (MB1707)

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • (no location specified)
Jul 18, 2022

Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

Recruiting
  • Recurrent Adult T-Cell Leukemia/Lymphoma
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Nov 18, 2022

Recurrent DLBCL, Recurrent High Grade B-Cell Lymphoma, Recurrent Transformed B-Cell Non-Hodgkin Lymphoma Trial in United States

Active, not recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +5 more
  • Mogamulizumab
  • Pembrolizumab
  • Sacramento, California
  • +7 more
Sep 15, 2022

COVID-19 Trial in Mexico City (Maraviroc + Currently used therapy, Curently used therapy for COVID-19 non-critical patients,

Terminated
  • COVID-19
  • Maraviroc + Currently used therapy
  • +3 more
  • Mexico City, Cdmx, Mexico
    Hospital General de México "Dr. Eduardo Liceaga"
May 31, 2022

Vasculitis, Diagnoses Disease Trial in Würzburg (CXCR4-PET)

Recruiting
  • Vasculitis
  • Diagnoses Disease
  • CXCR4-PET
  • Würzburg, Bayern, Germany
    Departement of Internal Medicine II, Rheumatology/Clinical Immun
Dec 4, 2022

Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

Active, not recruiting
  • Relapsed Adult ALL
  • Relapsed Adult AML
  • Changchun, Jilin, China
    First Hospital of Jilin University
Nov 19, 2023

Pancreatic Cancer Trial in Baltimore (Tislelizumab, SX-682)

Not yet recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Johns Hopkins SKCCC
Jan 23, 2023

Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

Recruiting
  • Mycosis Fungoides
  • +11 more
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +12 more
Jan 7, 2023

Neuroendocrine Tumors Trial in Iowa City ([68Ga]Pentixafor)

Recruiting
  • Neuroendocrine Tumors
  • Iowa City, Iowa
    Holden Comprehensive Cancer Center
Mar 16, 2022

Tumor Malignant Trial in Napoli (CLG)

Active, not recruiting
  • Neoplasm Malignant
  • CLG
  • Napoli, Italy
  • +1 more
Apr 18, 2023

CXCR4 in Patients With Systemic Lupus Erythematosus

Not yet recruiting
  • Systemic Lupus Erythematosus
    • (no location specified)
    Mar 14, 2021

    Type I Diabetes Trial in Pittsburgh (Ladarixin, Placebo)

    Withdrawn
    • Type I Diabetes
    • Pittsburgh, Pennsylvania
      Institute of Cellular Therapeutics Allegheny Health Network
    Jan 17, 2022